Skip to main content

Advertisement

Log in

Long-term changes of aortic 18F-FDG uptake and calcification in health-screening subjects

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Background

We investigated long-term changes in aortic 18F-fluorodeoxyglucose (18F-FDG) uptake and calcification in health-screening subjects and their relation with atherogenic risk factors.

Methods and results

A total of 94 consecutive subjects (72 men, 22 women; age 47–85 years, mean 57.9 years) participating in a health-screening protocol were evaluated retrospectively. All subjects had follow-up PET/CT scans 3.0–5.8 years (mean 4.1 years) later. We measured 18F-FDG uptake (maximum SUV) and calcium score (Agatston score) of the ascending, descending thoracic and infrarenal abdominal aorta on PET/CT images. 18F-FDG uptake and calcium score of the whole aorta (FUWA and CSWA) increased significantly in the follow-up study compared with the initial study (p = 0.02 and p < 0.0001, respectively). Multiple regression analysis showed that the change in FUWA per year was significantly associated with visceral fat area, while the change of CSWA per year was significantly associated with age and smoking habit. The degrees of 18F-FDG uptake and calcium score increases were significantly greater in the abdominal aorta than in the thoracic aorta (p = 0.05 and p < 0.0001, respectively).

Conclusions

Our data demonstrated the longitudinal progressions of vascular inflammation and calcification of health-screening subjects. Inflammation and calcification were observed to progress significantly faster in the abdominal aorta than in the thoracic aorta. The progressions of vascular inflammation and calcification may be associated with different atherogenic risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2009;36:144–51.

    Article  PubMed  Google Scholar 

  2. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol. 2010;55:2527–35.

    Article  PubMed  Google Scholar 

  3. Agatston A, Janowitz W, Hildner F, Zusmer N, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32.

    Article  PubMed  CAS  Google Scholar 

  4. Menezes LJ, Kotze CW, Hutton BF, Endozo R, Dickson JC, Cullum I, et al. Vascular inflammation imaging with 18F-FDG PET/CT: when to image? J Nucl Med. 2009;50:854–7.

    Article  PubMed  Google Scholar 

  5. Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. Quantification of atherosclerotic plaque activity and vascular inflammation using [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). J Vis Exp. 2012;63:e3777.

    PubMed  Google Scholar 

  6. Nakagawa K, Namba H, Iyo M, Fukushi K, Irie T, Yamanouchi M, et al. Simplified PET quantitation of myocardial glucose. J Nucl Med. 1995;36:2094–102.

    PubMed  CAS  Google Scholar 

  7. Yoshida K, Endo M, Fukuda H, Kagaya A, Himi T, Masuda Y, et al. Measurement of arterial tracer concentrations from cardiac PET images. J Comput Assist Tomogr. 1995;19:182–7.

    Article  PubMed  CAS  Google Scholar 

  8. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195(2):310–20.

    Article  PubMed  Google Scholar 

  9. Menezes LJ, Kayani I, Ben-Haim S, Hutton B, Ell PJ, Groves AM. What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque. Atherosclerosis. 2010;211(1):136–40.

    Article  PubMed  CAS  Google Scholar 

  10. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113–32.

    Article  PubMed  Google Scholar 

  11. Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg. 2005;30:476–88.

    Article  PubMed  CAS  Google Scholar 

  12. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2:107–15.

    Article  PubMed  Google Scholar 

  13. Tahara N, Kai H, Yamagishi S, Mizoguchi M, Nakaura H, Ishibashi M, et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533–9.

    Article  PubMed  CAS  Google Scholar 

  14. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging. 2008;35:319–28.

    Article  PubMed  Google Scholar 

  15. Ministry of Health, Labour and Welfare of Japan. NIPPON DATA (National Integrated Project for Prospective Observation of Non-communicable Disease And its Trends in the Age performed in Nov., 2010) http://www.mhlw.go.jp/toukei/saikin/hw/kenkou/jyunkan/jyunkan00/gaiyo.html (in Japanese). Accessed 21 Mar 2012.

  16. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831–7.

    Article  PubMed  Google Scholar 

  17. Dunphy MPS, Freiman A, Larson SM, Strauss HW. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278–84.

    PubMed  Google Scholar 

  18. Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111:816–28.

    Article  PubMed  Google Scholar 

  19. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis. 1985;5:293–302.

    Article  PubMed  CAS  Google Scholar 

  20. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995;75:519–60.

    PubMed  CAS  Google Scholar 

  21. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2009;29(10):1458–64.

    Article  PubMed  CAS  Google Scholar 

  22. Public Relations Office, Government of Japan. Taking Stock of the Ningen Dock, Highlighting Japan 2010. http://www.gov-online.go.jp/eng/publicity/book/hlj/html/201006/201006_04.html (in English). Accessed 7 Aug 2012.

  23. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825–31.

    Article  PubMed  CAS  Google Scholar 

  24. Wu YW, Kao HL, Huang CL, Chen MF, Lin LY, Wang YC, et al. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging. 2012;39(3):399–407.

    Article  PubMed  CAS  Google Scholar 

  25. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, et al. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging. 2011;4(10):1110–8.

    Article  PubMed  Google Scholar 

  26. Lee SJ, On YK, Lee EJ, Choi JY, Kim BT, Lee KH. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J Nucl Med. 2008;49:1277–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the staff of the PET Imaging Center and Health Screening Center at Asahi General Hospital for their skillful technical support. No potential conflicts of interest were disclosed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katsuya Yoshida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryu, Y., Yoshida, K., Suzuki, Y. et al. Long-term changes of aortic 18F-FDG uptake and calcification in health-screening subjects. Ann Nucl Med 27, 239–246 (2013). https://doi.org/10.1007/s12149-012-0679-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-012-0679-z

Keywords

Navigation